Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5904)
All Articles published online
|
Dec 7, 2012 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li YY. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18(45): 6546-6551 [PMID: 23236228 DOI: 10.3748/wjg.v18.i45.6546] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i45/6546.htm |
| Number | Citing Articles |
| 1 |
Xiao Xu, Xiaojie Deng, Yunzhi Chen, Wen Xu, Fen Xu, Hua Liang. SIRT1 mediates nutritional regulation of SREBP-1c-driven hepatic PNPLA3 transcription via modulation of H3k9 acetylation. Genes and Environment 2022; 44(1) doi: 10.1186/s41021-022-00246-1
|
| 2 |
Om Parkash, Subha Saeed. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018; doi: 10.5772/intechopen.71405
|
| 3 |
Hye-Lim Lee, Bo Yu, Peng Deng, Cun-Yu Wang, Christine Hong. Transforming Growth Factor-β-Induced KDM4B Promotes Chondrogenic Differentiation of Human Mesenchymal Stem Cells. Stem Cells 2016; 34(3): 711 doi: 10.1002/stem.2231
|
| 4 |
Nyasha C. Mukonowenzou, Rachael Dangarembizi, Eliton Chivandi, Pilani Nkomozepi, Kennedy H. Erlwanger. Administration of ursolic acid to new-born pups prevents dietary fructose-induced non-alcoholic fatty liver disease in Sprague Dawley rats. Journal of Developmental Origins of Health and Disease 2021; 12(1): 101 doi: 10.1017/S2040174420000124
|
| 5 |
Cynthia Aparecida de Castro, Manoela Maciel dos Santos Dias, Karina Ana da Silva, Sandra Aparecida dos Reis, Lisiane Lopes da Conceição, Letícia De Nadai Marcon, Luis Fernando de Sousa Moraes, Maria do Carmo Gouveia Peluzio. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 129 doi: 10.1007/978-94-007-7675-3_1
|
| 6 |
Li-jun Wang, Hong-wei Zhang, Jing-ya Zhou, Yan Liu, Yang Yang, Xiao-ling Chen, Cui-hong Zhu, Rui-dan Zheng, Wen-hua Ling, Hui-lian Zhu. Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet. The Journal of Nutritional Biochemistry 2014; 25(3): 329 doi: 10.1016/j.jnutbio.2013.11.007
|
| 7 |
Albert J. Czaja. Epigenetic changes and their implications in autoimmune hepatitis. European Journal of Clinical Investigation 2018; 48(4) doi: 10.1111/eci.12899
|
| 8 |
Joo Lee, Simonetta Friso, Sang-Woon Choi. Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition. Nutrients 2014; 6(8): 3303 doi: 10.3390/nu6083303
|
| 9 |
Jun Liang, Ying Liu, Jinguang Liu, Zhe Li, Qiangyuan Fan, Zifei Jiang, Fei Yan, Zhi Wang, Peiwen Huang, Nianping Feng. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD. Journal of Nanobiotechnology 2018; 16(1) doi: 10.1186/s12951-018-0391-9
|
| 10 |
Mayada Metwally, Mohammed Eslam, Jacob George. Genetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision Making. Current Hepatology Reports 2017; 16(4): 335 doi: 10.1007/s11901-017-0372-8
|
| 11 |
Gang Wu, Kai Wang, Yingming Xue, Guohe Song, Yupeng Wang, Xing Sun, Lin Zhong, Chongzhi Zhou, Bing Shen, Jian Chen, Yang Yu, Huamei Tang, Zhihai Peng, Peichun Sun, Xiaoliang Wang. Association of rs5764455 and rs6006473 polymorphisms in PARVB with liver damage of nonalcoholic fatty liver disease in Han Chinese population. Gene 2016; 575(2): 270 doi: 10.1016/j.gene.2015.09.007
|
| 12 |
Carlos Spichiger, Claudia Torres-Farfan, Hugo A. Galdames, Natalia Mendez, Pamela Alonso-Vazquez, Hans G. Richter. Gestation under chronic constant light leads to extensive gene expression changes in the fetal rat liver. Physiological Genomics 2015; 47(12): 621 doi: 10.1152/physiolgenomics.00023.2015
|
| 13 |
Norio Akuta, Yusuke Kawamura, Fumitaka Suzuki, Satoshi Saitoh, Yasuji Arase, Hideo Kunimoto, Yushi Sorin, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Mariko Kobayashi, Kenji Ikeda, Hiromitsu Kumada. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan. Hepatology International 2016; 10(4): 647 doi: 10.1007/s12072-016-9729-2
|
| 14 |
Ravi Adinarayan Somabattini, Sahla Sherin, Bhukya Siva, Neelanjan Chowdhury, Satheesh Kumar Nanjappan. Unravelling the complexities of non-alcoholic steatohepatitis: The role of metabolism, transporters, and herb-drug interactions. Life Sciences 2024; 351: 122806 doi: 10.1016/j.lfs.2024.122806
|
| 15 |
Mazen Noureddin, David Alexanian, Neil Kaplowitz. Lipid Management. 2015; : 149 doi: 10.1007/978-3-319-11161-2_9
|
| 16 |
Barbara Buday, Peter Ferenc Pach, Botond Literati-Nagy, Marta Vitai, Gyorgyi Kovacs, Zsuzsa Vecsei, Laszlo Koranyi, Csaba Lengyel. Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men?. Cardiovascular Diabetology 2015; 14(1) doi: 10.1186/s12933-015-0222-3
|
| 17 |
Yu Yuan Li, Dan Tang, Yan Lei Du, Chuang Yu Cao, Yu Qiang Nie, Jie Cao, Yong Jian Zhou. Fatty liver mediated by peroxisome proliferator‐activated receptor‐α DNA methylation can be reversed by a methylation inhibitor and curcumin. Journal of Digestive Diseases 2018; 19(7): 421 doi: 10.1111/1751-2980.12610
|
| 18 |
Liping Chen, Weifang Huang, Ling Wang, Zili Zhang, Feng Zhang, Shizhong Zheng, Desong Kong. The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism. Expert Review of Gastroenterology & Hepatology 2020; 14(4): 259 doi: 10.1080/17474124.2020.1736042
|
| 19 |
A. Viitasalo, J. Pihlajamaki, V. Lindi, M. Atalay, D. Kaminska, R. Joro, T. A. Lakka. Associations of I148M variant in PNPLA3 gene with plasma ALT levels during 2‐year follow‐up in normal weight and overweight children: the PANIC Study. Pediatric Obesity 2015; 10(2): 84 doi: 10.1111/ijpo.234
|
| 20 |
Amrita A. Khaire, Anvita A. Kale, Sadhana R. Joshi. Maternal omega-3 fatty acids and micronutrients modulate fetal lipid metabolism: A review. Prostaglandins, Leukotrienes and Essential Fatty Acids 2015; 98: 49 doi: 10.1016/j.plefa.2015.04.007
|
| 21 |
Rocío Gallego-Durán, Manuel Romero-Gómez. Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field. World Journal of Hepatology 2015; 7(24): 2497-2502 doi: 10.4254/wjh.v7.i24.2497
|
| 22 |
Cheng-Wei Li, Yu-Kai Chiu, Bor-Sen Chen. Investigating Pathogenic and Hepatocarcinogenic Mechanisms from Normal Liver to HCC by Constructing Genetic and Epigenetic Networks via Big Genetic and Epigenetic Data Mining and Genome-Wide NGS Data Identification. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/8635329
|
| 23 |
Ke Xu, Kenneth I. Zheng, Pei-Wu Zhu, Wen-Yue Liu, Hong-Lei Ma, Gang Li, Liang-Jie Tang, Rafael S. Rios, Giovanni Targher, Christopher D. Byrne, Xiao-Dong Wang, Yong-Ping Chen, Ming-Hua Zheng. Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis. Journal of Clinical and Translational Hepatology 2022; 10(2): 219 doi: 10.14218/JCTH.2021.00067
|
| 24 |
Ella A.M. van der Voort, Edith M. Koehler, Emmilia A. Dowlatshahi, Albert Hofman, Bruno H. Stricker, Harry L.A. Janssen, Jeoffrey N.L. Schouten, Tamar Nijsten. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study. Journal of the American Academy of Dermatology 2014; 70(3): 517 doi: 10.1016/j.jaad.2013.10.044
|
| 25 |
|
| 26 |
Itzayana Rodríguez-Antonio, Guillermo N. López-Sánchez, Victor Y. Garrido-Camacho, Misael Uribe, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development. HPB 2020; 22(11): 1513 doi: 10.1016/j.hpb.2020.07.011
|
| 27 |
|
| 28 |
Long-Xin Qiu, Tong Chen. Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease. World Journal of Gastroenterology 2015; 21(4): 1099-1107 doi: 10.3748/wjg.v21.i4.1099
|
| 29 |
Rui-Nan Zhang, Rui-Dan Zheng, Yu-Qiang Mi, Da Zhou, Feng Shen, Guang-Yu Chen, Chan-Yan Zhu, Qin Pan, Jian-Gao Fan. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases. Digestive Diseases and Sciences 2016; 61(8): 2284 doi: 10.1007/s10620-016-4120-7
|
| 30 |
Matthias Zilbauer, Aglaia Zellos, Robert Heuschkel, Marco Gasparetto, Judith Kraiczy, Jan Postberg, Luigi Greco, Renata Auricchio, Martina Galatola, Nicholas Embleton, Stefan Wirth, Andreas Jenke. Epigenetics in Paediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology and Nutrition 2016; 62(4): 521 doi: 10.1097/MPG.0000000000001053
|
| 31 |
Zhichao Liu, Yuping Wang, Jürgen Borlak, Weida Tong. Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades. Scientific Reports 2016; 6(1) doi: 10.1038/srep23709
|
| 32 |
Albert J. Czaja. Epigenetic Aspects and Prospects in Autoimmune Hepatitis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.921765
|
| 33 |
Adviti Naik, Rok Košir, Damjana Rozman. Genomic aspects of NAFLD pathogenesis. Genomics 2013; 102(2): 84 doi: 10.1016/j.ygeno.2013.03.007
|
| 34 |
David E. Amacher. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease. Biomarkers 2014; 19(7): 541 doi: 10.3109/1354750X.2014.958535
|
| 35 |
Jinhu Ma, Dandan You, Shuwen Chen, Nana Fang, Xinrui Yi, Yi Wang, Xuejin Lu, Xinyu Li, Meizi Zhu, Min Xue, Yunshu Tang, Xiaohui Wei, Jianzhen Huang, Yaling Zhu. Epigenetic Association Study Uncovered H3K27 Acetylation Enhancers and Dysregulated Genes in High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease in Rats. Epigenomics 2022; 14(23): 1523 doi: 10.2217/epi-2022-0362
|
| 36 |
Hiroya Yamada, Koji Ohashi, Koji Suzuki, Eiji Munetsuna, Yoshitaka Ando, Mirai Yamazaki, Hiroaki Ishikawa, Naohiro Ichino, Ryouji Teradaira, Shuji Hashimoto. Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease. Clinica Chimica Acta 2015; 446: 267 doi: 10.1016/j.cca.2015.05.002
|
| 37 |
Francesca M Trovato, Daniela Catalano, Adriana Garozzo, G Fabio Martines, Clara Pirri, Guglielmo M Trovato. ADV36 adipogenic adenovirus in human liver disease. World Journal of Gastroenterology 2014; 20(40): 14706-14716 doi: 10.3748/wjg.v20.i40.14706
|
| 38 |
Omar Ramos-Lopez, Erika Martinez-Lopez, Sonia Roman, Nora A Fierro, Arturo Panduro. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World Journal of Gastroenterology 2015; 21(41): 11552-11566 doi: 10.3748/wjg.v21.i41.11552
|
| 39 |
|
| 40 |
Norio Akuta, Yusuke Kawamura, Fumitaka Suzuki, Satoshi Saitoh, Yasuji Arase, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Mariko Kobayashi, Kenji Ikeda, Hiromitsu Kumada. Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0557-6
|
| 41 |
Qun Liu, Feng Xue, Jing Meng, Shou-Sheng Liu, Li-Zhen Chen, Hui Gao, Ning Geng, Wen-Wen Jin, Yong-Ning Xin, Shi-Ying Xuan. TRIB1 rs17321515 and rs2954029 gene polymorphisms increase the risk of non-alcoholic fatty liver disease in Chinese Han population. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1001-z
|
| 42 |
Zu-Yin Li, Gang Wu, Chen Qiu, Zhi-Jie Zhou, Yu-Peng Wang, Guo-He Song, Chao Xiao, Xin Zhang, Gui-Long Deng, Rui-Tao Wang, Yu-Long Yang, Xiao-Liang Wang. Mechanism and therapeutic strategy of hepatic <i>TM6SF2</i>-deficient non-alcoholic fatty liver diseases <i>via in vivo</i> and <i>in vitro</i> experiments. World Journal of Gastroenterology 2022; 28(25): 2937-2954 doi: 10.3748/wjg.v28.i25.2937
|
| 43 |
Amir Zarrinpar, Shakti Gupta, Mano R Maurya, Shankar Subramaniam, Rohit Loomba. Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study. Gut 2016; 65(9): 1546 doi: 10.1136/gutjnl-2015-309456
|
| 44 |
Philipp Zimmer, Alexander Schenk, Wilhelm Bloch. Körperliche Aktivität und Gesundheit. 2017; : 359 doi: 10.1007/978-3-662-50335-5_25
|
| 45 |
Jason R. Clapper, Michelle D. Hendricks, Guibao Gu, Carrie Wittmer, Carrie S. Dolman, John Herich, Jennifer Athanacio, Christiane Villescaz, Soumitra S. Ghosh, Joseph S. Heilig, Carolyn Lowe, Jonathan D. Roth. Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 305(7): G483 doi: 10.1152/ajpgi.00079.2013
|
| 46 |
Marcello Dallio, Mario Romeo, Antonietta Gerarda Gravina, Mario Masarone, Tiziana Larussa, Ludovico Abenavoli, Marcello Persico, Carmelina Loguercio, Alessandro Federico. Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives. Nutrients 2021; 13(5): 1679 doi: 10.3390/nu13051679
|
| 47 |
Mehmet Celikbilek, Mevlut Baskol, Serpil Taheri, Kemal Deniz, Serkan Dogan, Gokmen Zararsiz, Sebnem Gursoy, Kadri Guven, Omer Ozbakır, Munis Dundar, Mehmet Yucesoy. Circulating microRNAs in patients with non-alcoholic fatty liver disease. World Journal of Hepatology 2014; 6(8): 613-620 doi: 10.4254/wjh.v6.i8.613
|
| 48 |
Cynthia Aparecida de Castro, Manoela Maciel dos Santos Dias, Karina Ana da Silva, Sandra Aparecida dos Reis, Lisiane Lopes da Conceição, Letícia De Nadai Marcon, Luis Fernando de Sousa Moraes, Maria do Carmo Gouveia Peluzio. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_1-1
|
| 49 |
Beverly S Hong, Juan Liu, Jing Zheng, Weijian Ke, Zhimin Huang, Xuesi Wan, Xiaoying He, Haipeng Xiao, Yanbing Li. Angiopoietin‐like protein 8/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non‐alcoholic fatty liver disease patients. Journal of Diabetes Investigation 2018; 9(4): 952 doi: 10.1111/jdi.12792
|
| 50 |
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Archana Burman. Deciphering the role of aberrant DNA methylation in NAFLD and NASH. Heliyon 2022; 8(10): e11119 doi: 10.1016/j.heliyon.2022.e11119
|
| 51 |
Elena Buzzetti, Massimo Pinzani, Emmanuel A. Tsochatzis. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016; 65(8): 1038 doi: 10.1016/j.metabol.2015.12.012
|
| 52 |
Jooho Lee, Yuri Kim, Simonetta Friso, Sang-Woon Choi. Epigenetics in non-alcoholic fatty liver disease. Molecular Aspects of Medicine 2017; 54: 78 doi: 10.1016/j.mam.2016.11.008
|
| 53 |
Austin A. Ajah, Busisani W. Lembede, Pilani Nkomozepi, Kennedy H. Erlwanger, Trevor T. Nyakudya. Neonatal Oral Administration of Chrysin Prevents Long-Term Development of Non-Alcoholic Fatty Liver Disease in a Sexually Dimorphic Manner in Fructose Nurtured Sprague Dawley Rats. Life 2022; 12(6): 790 doi: 10.3390/life12060790
|
| 54 |
Chao Sun, Jian-Gao Fan, Liang Qiao. Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2015; 16(3): 5161 doi: 10.3390/ijms16035161
|
| 55 |
|
| 56 |
Swati Joshi-Barve, Irina Kirpich, Matthew C. Cave, Luis S. Marsano, Craig J. McClain. Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences. Cellular and Molecular Gastroenterology and Hepatology 2015; 1(4): 356 doi: 10.1016/j.jcmgh.2015.05.006
|
| 57 |
Kimberley D. Bruce, Felino R. Cagampang. Parental Obesity: Intergenerational Programming and Consequences. 2016; : 255 doi: 10.1007/978-1-4939-6386-7_12
|
| 58 |
Michelangela Barbieri, Antonietta Esposito, Edith Angellotti, Maria Rosaria Rizzo, Raffaele Marfella, Giuseppe Paolisso, Massimo Federici. Association of Genetic Variation in Adaptor Protein APPL1/APPL2 Loci with Non-Alcoholic Fatty Liver Disease. PLoS ONE 2013; 8(8): e71391 doi: 10.1371/journal.pone.0071391
|
| 59 |
KAZUHITO MIYACHI, YOUKI SAWADA, YOSUKE SHIDA, AKIRA SUGAWARA, HISASHI HISATOMI. Lipogenic gene expression profile in patients with gastric cancer. Molecular and Clinical Oncology 2013; 1(5): 825 doi: 10.3892/mco.2013.148
|
| 60 |
Lei Hao, Kyoko Ito, Kuan-Hsun Huang, Sudathip Sae-tan, Joshua D. Lambert, A. Catharine Ross. Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells. Metabolism 2014; 63(10): 1352 doi: 10.1016/j.metabol.2014.06.016
|
| 61 |
Lei Lei, Chao Zhou, Xue Yang, Liangping Li. Down‐regulation of microRNA‐375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non‐alcoholic fatty liver disease. Clinical and Experimental Pharmacology and Physiology 2018; 45(8): 819 doi: 10.1111/1440-1681.12940
|
| 62 |
Amar Mahgoub, Clifford Steer. MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases. Journal of Clinical Medicine 2016; 5(5): 52 doi: 10.3390/jcm5050052
|